AURA
Aura Biosciences, Inc.NASDAQHealthcare$6.54-2.39%ClosedMarket Cap: $415.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.94
P/S
0.00
EV/EBITDA
0.00
DCF Value
$0.67
FCF Yield
-20.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-71.2%
ROA
-62.7%
ROIC
-73.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-27.2M | $-25.6M | $-0.34 | — |
| FY 2025 | $0.00 | NaN% | $-112.8M | $-106.2M | $-1.76 | — |
| Q3 2025 | $0.00 | -Infinity% | $-27.9M | $-26.1M | $-0.40 | — |
| Q2 2025 | $0.00 | -Infinity% | $-28.6M | $-27.0M | $-0.47 | — |
| Q1 2025 | $0.00 | NaN% | $-29.0M | $-27.5M | $-0.55 | — |
| Q4 2024 | $0.00 | -Infinity% | $-27.8M | $-25.8M | $-0.52 | — |
| FY 2024 | $0.00 | NaN% | $-96.1M | $-86.9M | $-1.75 | — |
| Q3 2024 | $0.00 | NaN% | $-23.2M | $-21.0M | $-0.42 | — |
| Q2 2024 | $0.00 | NaN% | $-22.8M | $-20.3M | $-0.41 | — |
| Q1 2024 | $0.00 | -Infinity% | $-22.3M | $-19.7M | $-0.40 | — |
| Q4 2023 | $0.00 | -Infinity% | $-24.8M | $-22.1M | $-0.50 | — |
| FY 2023 | $0.00 | -Infinity% | $-85.0M | $-76.4M | $-1.93 | — |